Castleark Management LLC Penumbra Inc Transaction History

Castleark Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$240.69 - $338.77 $3.95 Million - $5.56 Million	-16,412 Reduced 77.67%	4,718 $1.14 Million
Q2 2023 Aug 15, 2023	SELL	$271.54 - $344.06 $1.11 Million - $1.41 Million	-4,100 Reduced 16.25%	21,130 $7.27 Million
Q4 2022 Feb 09, 2023	BUY	$151.88 - $228.5 $3.83 Million - $5.77 Million	25,230 New	25,230 $5.61 Million
Q2 2020 Aug 14, 2020	SELL	$153.32 - $191.72 $3.95 Million - $4.94 Million	-25,792 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$124.34 - $193.76 $3.21 Million - $5 Million	25,792 New	25,792 $4.16 Million
Q3 2018 Nov 15, 2018	SELL	$121.55 - $156.8 $3.15 Million - $4.06 Million	-25,890 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$112.2 - $165.95 $2.9 Million - $4.3 Million	25,890 New	25,890 $3.58 Million

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.